Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 1,390 | 1,114 | 1,976 | 1,231 | 1,806 |
| Cost of Goods | 535 | 452 | 1,855 | 552 | 568 |
| Gross Profit | 855 | 662 | 121 | 679 | 1,239 |
| Operating Expenses | 4,536 | 4,536 | 4,270 | 3,920 | 4,005 |
| Operating Income | -3,146 | -3,422 | -3,294 | -2,689 | -2,199 |
| Interest Expense | 269 | 289 | 233 | 229 | 230 |
| Other Income | 154 | 214 | 285 | 308 | 132 |
| Pre-tax Income | -3,261 | -3,498 | -3,242 | -2,611 | -2,297 |
| Net Income Continuous | -3,261 | -3,498 | -3,242 | -2,611 | -2,297 |
| Net Income | $-3,261 | $-3,498 | $-3,242 | $-2,611 | $-2,297 |
| EPS Basic Total Ops | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 |
| EPS Diluted Continuous Ops | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 |
| EBITDA(a) | $-3,013 | $-3,290 | $-1,002 | $-2,508 | $-2,028 |